Literature DB >> 26214410

Wnt1-induced MAFK expression promotes osteosarcoma cell proliferation.

R Wang1, J Zheng1, D-S Zhang1, Y-H Yang1, Z-F Zhao2.   

Abstract

Osteosarcoma is one of the most common primary bone tumors in children and young adults. In this study, we investigated the role of musculoaponeurotic fibrosarcoma oncogene homolog K (MAFK) in osteosarcoma cell proliferation in vitro and the possible pathways that contributed to MAFK-related osteosarcoma development. We first reported that MAFK was expressed at low levels in an osteosarcoma cell line. Furthermore, a significant correlation between MAFK and the Wnt signaling pathway was observed in osteosarcoma by using a gene microarray assay. We found that expression of MAFK could be induced by Wnt1 in a dose-dependent manner. Furthermore, Wnt1-induced MAFK expression caused a significant increase of cell viability, whereas a Wnt pathway inhibitor, IWR-1-endo, abolished Wnt1-induced effects on MAFK. Finally, cell cycle analysis showed that enhanced cell proliferation might be attributed to re-distribution of the cell cycle. Together, our results suggested that Wnt1-induced MAFK expression promoted cell proliferation in MG63 cells, and that the role of MAFK in osteosarcoma might be closely linked to the Wnt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26214410     DOI: 10.4238/2015.July.3.7

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  7 in total

Review 1.  Small Maf proteins (MafF, MafG, MafK): History, structure and function.

Authors:  Fumiki Katsuoka; Masayuki Yamamoto
Journal:  Gene       Date:  2016-04-05       Impact factor: 3.688

2.  MicroRNA-664-5p promotes myoblast proliferation and inhibits myoblast differentiation by targeting serum response factor and Wnt1.

Authors:  Rui Cai; Naren Qimuge; Meilin Ma; Yingqian Wang; Guorong Tang; Que Zhang; Yunmei Sun; Xiaochang Chen; Taiyong Yu; Wuzi Dong; Gongshe Yang; Weijun Pang
Journal:  J Biol Chem       Date:  2018-10-15       Impact factor: 5.157

3.  Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the Kidney.

Authors:  Ye Hong; Yi Que; Yang Hu; Bo-Yun Shi; Jia Zhu; Juan Wang; Jun-Ting Huang; Fei-Fei Sun; Lian Zhang; Xin-Ke Zhou; Su-Ying Lu; Yi-Zhuo Zhang
Journal:  Dis Markers       Date:  2022-06-15       Impact factor: 3.464

4.  Blocking fatty acid synthase inhibits tumor progression of human osteosarcoma by regulating the human epidermal growth factor receptor 2/phosphoinositide 3-kinase/protein kinase B signaling pathway in xenograft models.

Authors:  Xuan Yin Chen; Hui Bing Ruan; Xin Hua Long; Ai Fen Peng; Long Dian Zhou; Jia Ming Liu; Yang Zhou; Zhi Li Liu
Journal:  Exp Ther Med       Date:  2017-03-29       Impact factor: 2.447

Review 5.  Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.

Authors:  Pablo Angulo; Gaurav Kaushik; Dharmalingam Subramaniam; Prasad Dandawate; Kathleen Neville; Katherine Chastain; Shrikant Anant
Journal:  J Hematol Oncol       Date:  2017-01-07       Impact factor: 17.388

6.  A Novel Signature for Predicting Prognosis of Smoking-Related Squamous Cell Carcinoma.

Authors:  Chang Chen; Xiaoqing Cheng; Shuyan Li; Huanghui Chen; Mengjing Cui; Linlin Bian; Hui Jin
Journal:  Front Genet       Date:  2021-04-22       Impact factor: 4.599

7.  A Personalized Genomics Approach of the Prostate Cancer.

Authors:  Sanda Iacobas; Dumitru A Iacobas
Journal:  Cells       Date:  2021-06-30       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.